Intro slides from the event about Perfecting Partnerships for Life Sciences Startup Success co-organized by BaseLaunch operated by BaselArea.swiss and JLABS operated by Johnson & Johnson Innovation. The panel of seasoned deal makers included Sascha Bucher, Head Basel Roivant Pharma and Head of Global Transactions, Dominik Escher, Managing Partner BB Pureos Bioventures, Guenther Huhle, Head of JLABS EMEA, Johnson & Johnson Innovation, Carole Nuechterlein, Head of Roche Venture Fund and Markus Werner, VP Partnering of Molecular Partners. You find the event report here: https://www.baselaunch.ch/event-impressions-key-quotes-perfecting-partnerships-life-sciences-startup-success/

1. 1
Perfecting Partnerships for Life
Sciences Startup Success
21 MARCH | Basel
Moderated by:
Stephan Emmerth,
Director, Therapeutic Innovation
and BaseLaunch @ BaselArea
Sascha
Bucher
Dominik
Escher
Guenter
Huhle
Carole
Nuechterlein
Markus
Werner
Head of Basel
Roivant Pharma
and Head of Global
Transactions
Partner at Pureos
Bioventures
Head of JLABS
EMEA, Johnson &
Johnson Innovation
Head of Roche
Venture Fund
VP Partnering of
Molecular Partners

2. About BaselArea
Main activities
Develop the regional innovation ecosystem
and provide start-up support in
• Therapeutics and Biotech
• Healthcare
• Production & Industry
Lead foreign direct investment activities
Manage the Switzerland Innovation
Park Basel Area

3. Foreign Direct
Investment
Start-up Acceleration
& Incubation
Catalyst
Projects
Community
Events, Seminars
& Workshops
Collaborative
Workspaces
Strategic activities reinforcing each other across all focus industries
Events,
Seminars,
Workshops
Catalyst
Projects
Foreign
Direct
Investment
Community
Start-up
Acceleration &
Incubation
Collaborative projects that
tackle bottleneck issues in
innovation
How we do it
A vibrant community
connecting innovators,
entrepreneurs,
enthusiasts and experts
in all our focus industries
Different formals to
inform and connect
community, drive
collaboration, agenda
setting, and awareness
Space as neutral ground
for work and co-creation.
Space for start-up
acceleration
1
2
6
3
Advice during site
selection process.
Support during
relocation and
settlement
Individual Support during
company foundation.
Connection to experts and
investors
4
5

4. Building
transformative
biotech
ventures

5. What we do
Deep validation by selection panel
Industry access
& expertise
Senior team
build-out Infrastructure
Non-dilutive
funding
up to $250k
Derisking early stage ventures, both the science and the business

6. How we do it
Selection Committee

7. • Anaveon`s $35 Mio Series A led by Syncona
and joined by the Novartis Venture Fund
• Polyneuron`s $22.5 Mio Series A by Sofinnova
and NEA
• More to come…
Thorough selection primes for success

8. 8
JLABS @ BE –
the EMEA gateway to JLABS
and big company benefits
Guenter Huhle
Head of JLABS EMEA, Johnson & Johnson Innovation

9. 9
Johnson & Johnson Innovation – JLABS is a premier life science incubator
program and a global network of open innovation ecosystems, enabling and
empowering innovators to create and accelerate the delivery of life-enhancing
health and wellness solutions to patients around the world. As a leader in
innovation, JLABS helps entrepreneurs in pharmaceutical, medical device,
consumer, and health tech bring healthcare solutions to patients and consumers.
What is JLABS?
https://jlabs.jnjinnovation.com

10. 10
SAN DIEGO
January 2012
LOWELL, MASS
JLABS @ M2D2
December 2016
HOUSTON
JLABS @ TMC
March 2016
SHANGHAI
JLABS @ Shanghai
Opening 2019
TORONTO
JLABS @ TORONTO
September 2015
BOSTON
JLABS @ LABCENTRAL
June 2013
BOSTON IC
NYC
JLABS @ NYC
June 2018
SOUTH SAN
FRANCISCO
JLABS @ SSF
January 2013
BAY AREA
JLABS @ MBC BioLabs
June 2015
SAN FRANCISCO
IC
JPOD @ Boston
January 2019
JLABS JPOD
JLABS
PARTNERSHIPS
INNOVATION
CENTERS
LONDON
IC
SHANGHAI
IC
BEERSE, BE
JLABS @ BE
March, 2018
JPOD @ PHILADELPHIA
November 2018
JLABS Global Reach

11. 11
Activating Collaborative Local Ecosystems
building a coalition of academic institutions,
hospitals & industry organizations
Centralized Infrastructure
providing core capabilities so innovators can
dedicate precious capital to the science
Educational Programming
building skills, knowledge & networks to empower
and enable the local innovation community
Assets & Experts
providing big company support
Funding Series
connecting capital with innovators to increase the
volume and velocity of deal flow
Cross-Sector Focus
building an environment for solutions not just
products
Branding a Leading Cluster
utilizing corporate resources to brand, launch &
promote a region’s innovation
No Strings Attached
promoting open innovation to support
entrepreneurs build equity and value
Small
Companies
Get Big
Company
Benefits

12. 12
Perfecting Partnerships for Life
Sciences Startup Success
21 MARCH | Basel
Moderated by:
Stephan Emmerth,
Director, Therapeutic Innovation
and BaseLaunch @ BaselArea
Sascha
Bucher
Dominik
Escher
Guenter
Huhle
Carole
Nuechterlein
Markus
Werner
Head of Basel
Roivant Pharma
and Head of Global
Transactions
Partner at Pureos
Bioventures
Head of JLABS
EMEA, Johnson &
Johnson Innovation
Head of Roche
Venture Fund
VP Partnering of
Molecular Partners